Glaxosmithkline Pharma creeps higher on reporting 34% rise in FY12

19 Feb 2013 Evaluate

Glaxosmithkline Pharmaceuticals is currently trading at Rs 2097.00, up by 5.60 points or 0.27% from its previous closing of Rs 2091.40 on the BSE.

The scrip opened at Rs 2100.00 and has touched a high and low of Rs 2117.40 and Rs 2091.75 respectively. So far 1005 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 2338.00 on 30-Mar-2012 and a 52 week low of Rs 1916.00 on 04-Jul-2012.

Last one week high and low of the scrip stood at Rs 2126.05 and Rs 2051.15 respectively. The current market cap of the company is Rs 17717.75 crore.

The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.02% and 15.32% respectively.

GlaxoSmithKline Pharmaceuticals has reported 1.29% rise in its net profit at Rs 138.51 crore for fourth quarter ended December 31, 2012 as compared to Rs 136.74 crore for the same quarter in the previous year. Total income of the company has increased by 13.74% at Rs 704.34 crore for quarter under review as compared to Rs 619.25 crore for the quarter ended December 31, 2011.

For the entire 2012 fiscal, the company’s net profit surged 34.06% to Rs 577.26 crore from Rs 430.60 crore in the previous fiscal. The total income from operations went up by 11.37% to Rs 2823.78 crore from Rs 2535.50 crore in last year.

Glaxosmithkline Phar Share Price

2543.40 0.30 (0.01%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×